Custom OEM/ODM Softgels, Capsules, Powders & Functional Gummies Engineered under cGMP Standards
The global market for marine-derived Omega-3 fatty acids—specifically Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA)—has undergone a fundamental structural transformation. Modern nutraceutical brand owners, pharmaceutical procurement directors, and retail category managers no longer view fish oil softgel encapsulation as a simple commodity blending process. Today, securing market leadership requires working with specialized OEM/ODM fish oil factories capable of maintaining stringent lipid stability, sophisticated molecular purification, and documented compliance with international regulatory bodies.
"Information Gain in Marine Lipid Sourcing: The modern competitive advantage lies in controlling the oxidation curve. Achieving a total oxidation (TOTOX) score under 10 meq/kg through closed-loop nitrogen blanket handling and re-esterified triglyceride (rTG) bio-availability is the definitive gold standard for tier-1 supplement brands."
Contract manufacturing of fish oil requires specialized technical infrastructure. Crude fish oil harvested from wild-caught cold-water species (such as Peruvian Anchoveta, Pacific Sardines, or Atlantic Mackerel) contains varying ratios of natural triglycerides, free fatty acids, heavy metals (mercury, lead, cadmium), environmental contaminants (PCBs, dioxins, furans), and lipid peroxides. Transforming raw lipid stock into stable, bioavailable, odorless, and highly concentrated softgel supplements requires a multi-stage pharmaceutical refining process.
As a premier U.S.-based contract manufacturer established in 1995, Bactolac Pharmaceutical, Inc. provides turn-key contract manufacturing services operating under strict FDA 21 CFR Part 111 cGMP regulations. By unifying raw material purification, custom softgel formulation, analytical release testing, and high-speed packaging under a single quality management unit, Bactolac eliminates supply chain fragmentation for global supplement brands.
Why Tier-1 Global Health Brands Partner with Bactolac Pharmaceutical for OEM/ODM Solutions
Founded in 1995 in Hauppauge, New York, Bactolac operates over 350,000 sq. ft. of state-of-the-art production suites. We hold FDA 21 CFR Part 111 cGMP compliance alongside NSF, NPA, USDA Organic handling, Kosher, and Halal certifications.
Every raw material batch is quarantined and analyzed on-site. Our analytical laboratories utilize ICP-MS, HPLC, GC-FID, and UV-Vis spectrophotometry to test for potency, heavy metals, microbial limits, and oxidation parameters (PV and AV) prior to batch release.
We engineer custom softgels ranging from standard 18/12 EPA/DHA ratios to high-potency 80% concentrates. Capabilities include gelatin and vegetarian HPMC shells, enteric target release coatings, natural citrus odor-masking, and nitrogen-purged bottling.
Understanding the structural forms of Omega-3 fatty acids is critical for procurement managers seeking to position their products in premium retail channels. In raw fish oil, EPA and DHA exist as natural triglycerides (TG), bound to a glycerol backbone alongside saturated fats. To concentrate the active EPA/DHA payload, contract factories execute a sequence of chemical engineering operations:
| Molecular Form | EPA/DHA Concentration | Human Bioavailability | Oxidation Stability | Production Cost / MOQ |
|---|---|---|---|---|
| Natural Triglyceride (TG) | 18% EPA / 12% DHA (30% total) | Baseline (100%) | High natural stability | Low Cost / Standard MOQ |
| Ethyl Ester (EE) | 50% to 85% Concentrated | Moderate (73%) | Requires Nitrogen Shield | Moderate Cost / Scalable |
| Re-esterified Triglyceride (rTG) | 60% to 90%+ Ultra-High | Superior (170%+) | Optimal Structural Resistance | Premium Grade / Contract OEM |
| Phosphate Bound (Algae/Krill) | 40% to 50% Specialized | High Absorption | High (Contains Astaxanthin) | Specialty Sourcing |
Key Innovation Drivers Shaping the Next Decade of Omega-3 Sourcing
Consumers prefer smaller softgels with higher active dosages. Bulk procurement is migrating from standard 1000mg 18/12 softgels toward 500mg mini-softgels delivering 400mg active EPA/DHA per pill via rTG technology.
Major European and North American retailers require Marine Stewardship Council (MSC) or Friend of the Sea (FOS) certification. Documenting exact fishery coordinates and low-carbon harvest methods is now a mandatory prerequisite.
Vegan Omega-3 derived from Schizochytrium sp. microalgae is achieving cost-parity with marine fish oils. Dual-track contract manufacturing for both marine and algal softgels is rapidly expanding.
Phthalate-free enteric softgel technology bypasses the acidic stomach environment entirely, eliminating reflux and "fishy burps" while delivering un-degraded Omega-3 directly to the small intestine for absorption.
Technical and Logistics Solutions for Brand Owners & Sourcing Officers
Consult with our senior formulation scientists and project leaders to develop high-potency, stable, market-ready softgel, capsule, powder, or gummy products today.